295 related articles for article (PubMed ID: 29150948)
21. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers.
Saulnier A; Vaissière T; Yue J; Siouda M; Malfroy M; Accardi R; Creveaux M; Sebastian S; Shahzad N; Gheit T; Hussain I; Torrente M; Maffini FA; Calabrese L; Chiesa F; Cuenin C; Shukla R; Fathallah I; Matos E; Daudt A; Koifman S; Wünsch-Filho V; Menezes AM; Curado MP; Zaridze D; Boffetta P; Brennan P; Tommasino M; Herceg Z; Sylla BS
Int J Cancer; 2012 Jun; 130(11):2484-94. PubMed ID: 21796618
[TBL] [Abstract][Full Text] [Related]
23. Expression of DOK1, 2, and 3 genes in HTLV-1-infected T cells.
Ohsugi T; Wakamiya M; Morikawa S; Fujita M
Acta Virol; 2016 Jun; 60(2):211-3. PubMed ID: 27265473
[TBL] [Abstract][Full Text] [Related]
24. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia.
Zhang TJ; Wang YX; Yang DQ; Yao DM; Yang L; Zhou JD; Deng ZQ; Wen XM; Guo H; Ma JC; Lin J; Qian J
Clin Lab; 2016; 62(1-2):113-20. PubMed ID: 27012040
[TBL] [Abstract][Full Text] [Related]
25. Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
Hájková H; Marková J; Haškovec C; Sárová I; Fuchs O; Kostečka A; Cetkovský P; Michalová K; Schwarz J
Leuk Res; 2012 Sep; 36(9):1128-33. PubMed ID: 22749068
[TBL] [Abstract][Full Text] [Related]
26. SMG1 acts as a novel potential tumor suppressor with epigenetic inactivation in acute myeloid leukemia.
Du Y; Lu F; Li P; Ye J; Ji M; Ma D; Ji C
Int J Mol Sci; 2014 Sep; 15(9):17065-76. PubMed ID: 25257528
[TBL] [Abstract][Full Text] [Related]
27. CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.
Li M; Gao L; Li Z; Sun J; Zhang H; Duan H; Ma Y; Wang C
Oncotarget; 2016 May; 7(21):31454-65. PubMed ID: 27129146
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.
Kühnl A; Valk PJ; Sanders MA; Ivey A; Hills RK; Mills KI; Gale RE; Kaiser MF; Dillon R; Joannides M; Gilkes A; Haferlach T; Schnittger S; Duprez E; Linch DC; Delwel R; Löwenberg B; Baldus CD; Solomon E; Burnett AK; Grimwade D
Blood; 2015 May; 125(19):2985-94. PubMed ID: 25805812
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of pseudogene Vimentin 2p is associated with poor outcome in de novo acute myeloid leukemia.
Zhai LL; Zhou J; Zhang J; Tang X; Zhou LY; Yin JY; Vanessa MD; Peng W; Lin J; Deng ZQ
Cancer Biomark; 2017; 18(3):305-312. PubMed ID: 28106537
[TBL] [Abstract][Full Text] [Related]
30. The clinical significance of the alternative Wilms tumor gene overexpression-hypermethylation signature in acute myeloid leukemia.
El Bordiny M; Al-Ghandour A; Abo Elwafa RA; Fayed O
Clin Transl Oncol; 2019 Jul; 21(7):864-873. PubMed ID: 30506133
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and prognostic significance of ABO promotor methylation level in adult leukemia and myelodydysplastic syndrome].
Shao M; Tang P; Lyu XP; Yang QK; Zhu WT; Jin HF; Wang L; Zhao XQ; Liu X; Sun L
Zhonghua Nei Ke Za Zhi; 2018 Nov; 57(11):816-823. PubMed ID: 30392237
[No Abstract] [Full Text] [Related]
32. Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
Qu X; Othus M; Davison J; Wu Y; Yan L; Meshinchi S; Ostronoff F; Estey EH; Radich JP; Erba HP; Appelbaum FR; Fang M
Cancer; 2017 Jul; 123(13):2472-2481. PubMed ID: 28222251
[TBL] [Abstract][Full Text] [Related]
33. DDX43 promoter is frequently hypomethylated and may predict a favorable outcome in acute myeloid leukemia.
Lin J; Chen Q; Yang J; Qian J; Deng ZQ; Qian W; Chen XX; Ma JC; Xiong DS; Ma YJ; An C; Tang CY
Leuk Res; 2014 May; 38(5):601-7. PubMed ID: 24656837
[TBL] [Abstract][Full Text] [Related]
34. Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer.
Friedrich T; Söhn M; Gutting T; Janssen KP; Behrens HM; Röcken C; Ebert MPA; Burgermeister E
EBioMedicine; 2016 Jun; 8():159-172. PubMed ID: 27428427
[TBL] [Abstract][Full Text] [Related]
35. DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia.
Zhang YY; Yao DM; Zhu XW; Zhou JD; Ma JC; Yang J; Wen XM; Guo H; Lin J; Qian J
Leuk Res; 2015 Oct; 39(10):1041-7. PubMed ID: 26242829
[TBL] [Abstract][Full Text] [Related]
36. Effects of expressing human T-cell leukemia virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice.
Ohsugi T
J Vet Med Sci; 2017 May; 79(5):935-938. PubMed ID: 28302940
[TBL] [Abstract][Full Text] [Related]
37. Relationship between epigenetic changes in Wnt antagonists and acute leukemia.
Zhou HR; Fu HY; Wu DS; Zhang YY; Huang SH; Chen CJ; Yan JG; Huang JL; Shen JZ
Oncol Rep; 2017 May; 37(5):2663-2671. PubMed ID: 28440495
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognosis analysis of
Zhang T; Zhao Y; Zhao Y; Zhou J
Aging (Albany NY); 2020 Mar; 12(6):5031-5047. PubMed ID: 32209730
[No Abstract] [Full Text] [Related]
39. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
Araújo OC; Rosa AS; Fernandes A; Niel C; Villela-Nogueira CA; Pannain V; Araujo NM
PLoS One; 2016; 11(4):e0153796. PubMed ID: 27078152
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
